Table 3.
Characterization results of liposomal formulation.
| Formulations | Size (nm) | PDI | Zeta Potential (mV) |
|---|---|---|---|
| Peptide Liposomes | 156.2 ± 0.5 | 0.255 ± 0.02 | -7 ± 0.57 |
| Rifampicin Liposomes | 181 ± 5.2 | 0.151 ± 0.01 | -6 ± 1.15 |
| Azithromycin Liposomes |
210 ± 2.3 | 0.125 ± 0.01 | -3 ± 0.57 |
| Peptide-Rifampicin Liposomes |
220 ± 8.27 | 0.214 ± 0.03 | -4 ± 1.15 |
| Peptide-Azithromycin Liposomes |
232 ± 1.36 | 0.162 ± 0.06 | -5 ± 1.23 |
| Blank Formulation | 126 ± 5.24 | 0.142 ± 0.04 | -7 ± 1.15 |
Each value represents the mean ± standard deviation of three measurements.